Clinical and biomarker changes in dominantly inherited Alzheimer's disease RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ... New England Journal of Medicine 367 (9), 795-804, 2012 | 4221 | 2012 |
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 573 | 2018 |
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease TLS Benzinger, T Blazey, CR Jack Jr, RA Koeppe, Y Su, C Xiong, ... Proceedings of the National Academy of Sciences 110 (47), E4502-E4509, 2013 | 418 | 2013 |
Loss of brain aerobic glycolysis in normal human aging MS Goyal, AG Vlassenko, TM Blazey, Y Su, LE Couture, TJ Durbin, ... Cell metabolism 26 (2), 353-360. e3, 2017 | 285 | 2017 |
Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers R Potter, BW Patterson, DL Elbert, V Ovod, T Kasten, W Sigurdson, ... Science translational medicine 5 (189), 189ra77-189ra77, 2013 | 266 | 2013 |
Partial volume correction in quantitative amyloid imaging Y Su, TM Blazey, AZ Snyder, ME Raichle, DS Marcus, BM Ances, ... Neuroimage 107, 55-64, 2015 | 238 | 2015 |
Quantitative analysis of PiB-PET with freesurfer ROIs Y Su, GM D'Angelo, AG Vlassenko, G Zhou, AZ Snyder, DS Marcus, ... PloS one 8 (11), e73377, 2013 | 229 | 2013 |
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging BA Gordon, K Friedrichsen, M Brier, T Blazey, Y Su, J Christensen, ... Brain 139 (8), 2249-2260, 2016 | 197 | 2016 |
Lag threads organize the brain’s intrinsic activity A Mitra, AZ Snyder, T Blazey, ME Raichle Proceedings of the National Academy of Sciences 112 (17), E2235-E2244, 2015 | 192 | 2015 |
Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ... Brain 142 (4), 1063-1076, 2019 | 163 | 2019 |
Persistent metabolic youth in the aging female brain MS Goyal, TM Blazey, Y Su, LE Couture, TJ Durbin, RJ Bateman, ... Proceedings of the National Academy of Sciences 116 (8), 3251-3255, 2019 | 161 | 2019 |
Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype S Mishra, TM Blazey, DM Holtzman, C Cruchaga, Y Su, JC Morris, ... Brain 141 (6), 1828-1839, 2018 | 142 | 2018 |
Effects of white matter injury on resting state fMRI measures in prematurely born infants CD Smyser, AZ Snyder, JS Shimony, TM Blazey, TE Inder, JJ Neil PloS one 8 (7), e68098, 2013 | 139 | 2013 |
Functional connectivity in autosomal dominant and late-onset Alzheimer disease JB Thomas, MR Brier, RJ Bateman, AZ Snyder, TL Benzinger, C Xiong, ... JAMA neurology 71 (9), 1111-1122, 2014 | 121 | 2014 |
Longitudinal β-amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non–Alzheimer disease pathophysiology BA Gordon, T Blazey, Y Su, AM Fagan, DM Holtzman, JC Morris, ... JAMA neurology 73 (10), 1192-1200, 2016 | 114 | 2016 |
Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease AG Vlassenko, BA Gordon, MS Goyal, Y Su, TM Blazey, TJ Durbin, ... Neurobiology of aging 67, 95-98, 2018 | 94 | 2018 |
Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology BA Gordon, A McCullough, S Mishra, TM Blazey, Y Su, J Christensen, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10, 245-252, 2018 | 88 | 2018 |
Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease L Wang, TL Benzinger, J Hassenstab, T Blazey, C Owen, J Liu, AM Fagan, ... Neurology 84 (12), 1254-1260, 2015 | 86 | 2015 |
Quantitative amyloid imaging in autosomal dominant Alzheimer’s disease: results from the DIAN study group Y Su, TM Blazey, CJ Owen, JJ Christensen, K Friedrichsen, ... PLoS One 11 (3), e0152082, 2016 | 63 | 2016 |
Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease Q Wang, Y Wang, J Liu, CL Sutphen, C Cruchaga, T Blazey, BA Gordon, ... NeuroImage: Clinical 22, 101767, 2019 | 60 | 2019 |